3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion
3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion je antagonist alfa adrenergičkog receptora.[3]
![]() | |
Nazivi | |
---|---|
Preferisani IUPAC naziv
3-[4-[4-(3-metilfenil)piperazin-1-il]butil]imidazolidin-2,4-dion | |
Drugi nazivi
3-(4-(4-(3-metilfenil)-1-piperazinil)butil)-2,4-imidazolindion
CI 926 CI-926 PD 78787 PD-78787 104683-52-5 CI 926 3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion 3-[4-[4-(3-metilfenil)piperazin-1-il]butil]imidazolidin-2,4-dion UF97L75CUS PD 78787 2,4-Imidazolidinedion, 3-(4-(4-(3-metilfenil)-1-piperazinil)butil) CI-926 UNII-UF97L75CUS SCHEMBL11067178 DTXSID50146649 AKOS034512249 PD162507 PD-78,787 Z649995780 3-[4-[4-(3-metil-fenil)-1-piperazinil]butil]-2,4-imidazolinedion | |
Identifikacija | |
3D model (Jmol)
|
|
UNII | |
| |
Svojstva | |
C18H26N4O2 | |
Molarna masa | 330,43 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Reference
уреди- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ R L Susick Jr; R A Jordan; J R Watkins (1991). „Cataracts in dogs following subchronic administration of the phenylpiperazine antihypertensive agent PD 78787”. Fundam Appl Toxicol. стр. 593—600. doi:10.1016/0272-0590(91)90209-m.